Skip to Content
  • Article
  • Open Access

31 March 2026

17 Pages

Exosome Biogenesis: Meta-Analysis of Intraluminal Vesicle Size Across Species

,
,
,
,
,
,
,
,
1
HCEMM-SU Extracellular Vesicle Research Group, 1089 Budapest, Hungary
2
Institute of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Hungary
3
Division of Medical Oncology, Modena University Hospital, 41124 Modena, Italy
4
HUN-REN-SU Translational Extracellular Vesicle Research Group, 1089 Budapest, Hungary
This article belongs to the Section Molecular Biology

Abstract

Exosomes, a major subpopulation of small extracellular vesicles (sEV), are conserved mediators of intercellular communication, yet the properties of their endosomal precursors, intraluminal vesicles (ILV), have not been systematically quantified across species or imaging modalities. This study systematically evaluates ILV sizes across diverse eukaryotic species and modalities while assessing their relationship to secreted sEV sizes. We carried out two complementary meta-analyses of ILV sizes based on transmission electron microscopy (TEM) and cryogenic electron microscopy (cryo-EM) data across species. This was followed by in situ assessment of sEVs secreted by HEK293T cells with TEM, nanoparticle tracking analysis and super-resolution microscopy characterization. Across species, imaging modalities, and cellular contexts, ILV sizes were under approximately 200 nm, with a mean diameter of 100.5 nm, overlapping with the size range of sEVs. This study addresses an existing knowledge gap by systematically evaluating ILV size across species and revealing an upper size limit of approximately 200 nm.

1. Introduction

The field of extracellular vesicle (EV) research has progressed significantly in recent decades, elucidating the complex nature and increasing potential of EVs for disease diagnosis and therapy [1,2,3,4,5,6,7]. EVs have been shown to participate in both the progression and inhibition of various conditions, including cancer [8], cardiovascular disorders [4,9], and neurological diseases [10].
EV biogenesis is generally described as occurring through two principal pathways. In one route, vesicles, often termed ectosomes, are generated by direct outward budding from the plasma membrane. In the second route, vesicles termed exosomes are formed as intraluminal vesicles (ILVs) within multivesicular bodies (MVBs) or amphisomes, which are subsequently released into the extracellular space following fusion of the limiting membrane of MVBs or amphisomes with the plasma membrane [11,12,13,14]. ILV formation of MVBs is mediated by the endosomal sorting complexes required for transport (ESCRT), which coordinate cargo recognition and membrane scission, while lipid-rich microdomains and membrane curvature drive the inward invagination. ESCRT independent mechanisms involving lipid microdomains, ceramide, and tetraspanins generate structurally distinct ILV populations with potentially different sizes, indicating multiple molecular routes to ILV biogenesis [15,16,17].
EV secretion has been reported across all domains of life [18]. Yet, the quantitative properties of ILVs, particularly their size, have not been systematically evaluated across species. Although the molecular mechanisms of ILV biogenesis have been extensively characterized, it remains unclear whether ILVs generated through ESCRT-dependent or ESCRT-independent pathways exhibit common sizes across organisms. Reported ILV sizes vary considerably in the literature, most commonly ranging from 30 to 150 nm [19,20] depending on cell type and detection methodology, although larger vesicles have occasionally been reported, and the impact of imaging modality has not been systematically compared. Transmission electron microscopy (TEM) is predominantly used, while cryogenic electron microscopy (cryo-EM), which avoids fixation artifacts and better preserves native membrane architecture, has been applied less frequently.
In this study, a comprehensive and integrative approach was undertaken to address these gaps. Two independent meta-analyses were performed to evaluate ILV sizes across species based on published TEM and cryo-EM-based studies, enabling direct comparison between imaging modalities. In addition, sEVs were isolated from HEK293T cells and characterized to examine the relationship between ILV dimensions and the size of secreted vesicles. Together, these analyses were designed to establish a quantitative framework for ILV size conservation and to clarify its relationship to exosome and sEV sizes across systems.

2. Results

2.1. Conserved Intraluminal Vesicle Size Across Species Revealed by TEM Meta-Analysis

To determine whether ILV size varies across species, a comprehensive meta-analysis of previously published studies indexed in PubMed was performed. Two independent meta-analyses were conducted. In the first analysis, only studies in which ILVs were characterized by using TEM were used. For each selected study, ILV diameters were estimated from TEM micrographs using scale bar calibration (Supplementary Information Figure S1). Individual ILVs within MVBs were measured, and the organism used in each study was recorded. The number of ILVs measured (N), mean diameter, standard deviation (SD), and lower and upper limits of the 95% confidence interval (CI) were calculated and summarized in Table 1. ILVs were analyzed across a broad range of species, including human, goat, rat, mouse, turtle, fish, Caenorhabditis elegans, insects, isopods, crustaceans, fungi, plants, and green algae (Figure 1C). Across all species, the mean ± SD of ILV diameter was 112.05 ± 26.79 nm. The largest ILVs were observed in plant-derived samples, with diameters reaching up to 197 nm, whereas the smallest ILVs, measuring approximately 25 nm in diameter, were observed in Caenorhabditis elegans. Notably, the upper limit of ILV diameter remained below 200 nm across all species examined. The frequency distribution of ILV diameters exhibited a unimodal, right-skewed profile, with the majority of ILVs measuring between approximately 40 and 120 nm (Figure 1D). The distribution peaked around 60–80 nm, and progressively fewer ILVs exceeded 100 nm in diameter. The dashed red line at 200 nm indicates that all measured ILVs were smaller than this threshold. Human-derived studies constituted the largest proportion of the dataset, followed by studies in plants, fish, green algae, mice, and rats. Additional taxa—including fungi, goat, insects, isopods, turtle, Caenorhabditis elegans, and planktonic crustaceans—were each represented by a single study, highlighting the phylogenetic diversity of biological systems in which ILVs were analyzed (Figure 1E). Collectively, ILVs measured from TEM micrographs across all examined species were consistently observed to be smaller than 200 nm in diameter.
Table 1. Summary of intraluminal vesicle (ILV) diameter measurements obtained from TEM-based studies included in the meta-analysis. This table summarizes quantitative ILV size measurements extracted from TEM micrographs across all studies included in the TEM-based meta-analysis. For each study, the organism examined, the number of ILVs measured (N), mean ILV diameter, standard deviation (SD), and lower and upper limits of the 95% confidence interval (CI) are reported. The graphical representation can be found in the Supplementary Information Figure S2A.
Figure 1. Meta-analysis of intraluminal vesicle (ILV) size measured by TEM across species. (A) PRISMA-based workflow illustrating the literature search, screening, and inclusion strategy used to identify TEM-based studies reporting ILV measurements. A total of 895 records were retrieved from PubMed, of which 40 studies met the inclusion criteria. (B) Schematic representation of ILVs was measured in ImageJ (v1.54g) in situ images after scale calibration, by freehand tool selection and Feret diameter quantification. (C) Violin plots show the distribution of ILV diameters across species derived from TEM micrographs included in the meta-analysis. Descriptive statistics are summarized with the symbols for the respective species as follows: human (N = 245; mean = 92.87; SD = 38.97), goat (N = 9; mean = 119.6; SD = 34.57), rat (N = 41; mean = 64.82; SD = 14.13), mouse (N = 18; mean = 119.4; SD = 45.84), turtle (N = 23; mean = 133.3; SD = 30.85), fish (N = 46; mean = 117.1; SD = 26.28), c. elegans (N = 59; mean = 61.05; SD = 10.34), insects (N = 8; mean = 141.9; SD = 32.28), isopods (N = 17; mean = 41.62; SD = 6.994), crustacean (N = 7; mean = 163; SD = 15.38), fungus (N = 10; mean = 142.4; SD = 26.49), plant (N = 102; mean = 128.4; SD = 35.54), green alga (N = 46; mean = 131.3; SD = 30.56). Here, N is the number of ILV measured. (D) Frequency distribution of ILV diameters measured from TEM micrographs across all included studies. The distribution exhibits a unimodal profile with a right-skewed tail. The dashed red line indicates the 200 nm upper size reference, above which only a small fraction of ILVs were observed. (E) A burst pie chart illustrating that most peer-reviewed articles studied human samples, followed by plant, mouse, fish, algae, and rat. The number represents the number of studies per species.

2.2. Conserved Intraluminal Vesicle Size Across Species Revealed by Cryo-EM Meta-Analysis

To assess whether variability in ILV size may arise from technical limitations associated with TEM, a second meta-analysis was performed focusing on ILV measurements obtained using cryo-EM. Individual ILVs within MVBs were measured, and the organism used in each study was recorded. The number of ILVs measured (N), mean diameter, SD, and lower and upper limits of the 95% CI were calculated and summarized in Table 2. ILVs were analyzed across multiple species, including human, monkey, rat, mouse, and fungi (Figure 2B). The majority of ILV diameters were below 200 nm; however, a single ILV measured in a monkey-derived sample exhibited a diameter of 205.54 nm, representing 1 out of 86 ILVs analyzed. The frequency distribution of ILV diameters derived from cryo-EM datasets exhibited a narrow, unimodal profile, with most ILVs measuring between approximately 40 and 90 nm (Figure 2C). The distribution peaked around 50–60 nm, and only a single ILV exceeded 200 nm, while most measurements fell within the 200 nm upper limit indicated by the dashed red line. The species distribution of studies included in the cryo-EM meta-analysis is shown in Figure 2D. Human-derived studies constituted the largest proportion of the dataset, followed by mouse-derived studies, whereas monkey, rat, and fungal samples were each represented by a single study. Mean ILV diameters ± SD obtained from TEM and cryo-EM-based studies were compared, revealing that ILVs measured by TEM were significantly larger and had higher variability than those measured by cryo-EM (Figure 2E). Comparison of the two imaging modalities’ statistics is shown in Table 3. The average mean ± SD of ILV diameter of combined studies is 100.5 ± 39.12 nm. Despite this difference, cryo-EM-derived ILV sizes remained predominantly below the 200 nm upper size limit and were largely consistent with TEM-based measurements.
Table 2. Summary of intraluminal vesicle (ILV) diameter measurements obtained from cryo-EM-based studies included in the meta-analysis. This table summarizes quantitative ILV size measurements extracted from cryo-EM micrographs across all studies included in the cryo-EM-based meta-analysis. For each study, the organism examined, number of ILVs measured (N), mean ILV diameter, standard deviation (SD), and lower and upper limits of the 95% confidence interval (CI) are reported. The graphical representation can be found in the Supplementary Information Figure S2B.
Figure 2. Meta-analysis of intraluminal vesicle (ILV) size measured by cryo-EM and comparison with TEM-derived measurements. (A) PRISMA-based workflow illustrating the literature search, screening, and inclusion strategy for cryo-EM-based studies reporting ILV measurements. A total of 11 records were retrieved from PubMed, of which 8 studies met the inclusion criteria. (B) Violin plots showing species-specific distributions of ILV diameters measured by cryo-EM across species as showed with symbol respectively. Descriptive statistics are summarized as follows: human (N = 15; mean = 64.05 nm; SD = 22.27 nm; 95% CI = 51.72–76.39 nm), monkey (N = 9; mean = 153.3 nm; SD = 34.58 nm; 95% CI = 126.7–179.9 nm), rat (N = 7; mean = 46.38 nm; SD = 8.675 nm; 95% CI = 41.92–50.85 nm), mouse (N = 5; mean = 63.50 nm; SD = 13.42 nm; 95% CI = 57.96–69.04 nm), and fungus (N = 2; mean = 43.68 nm; SD = 5.074 nm; 95% CI = 41.31–46.06 nm). Here, N is the number of ILV measured per species. (C) Frequency distribution of pooled ILV diameters measured by cryo-EM across all included studies. The distribution exhibits a unimodal profile centered in the sub-100 nm range. The dashed red line denotes the 200 nm upper size reference. (D) Burst pie chart illustrating the taxonomic composition of the cryo-EM dataset, indicating the relative contribution of human, monkey, mouse, rat, and fungal studies to the pooled analysis. (E) Comparison of ILV diameters measured by TEM and cryo-EM. Statistical analysis was performed using an unpaired Welch’s t-test (two-tailed). Mean ILV diameter measured by TEM was 109.6 nm, whereas the mean ILV diameter measured by cryo-EM was 70.37 nm. The difference between means was 39.25 ± 14.12 nm, with a 95% CI of 7.859–70.65 nm. The difference was statistically significant (* = p < 0.005). Sample sizes were N = 39 for TEM and N = 8 for cryo-EM. The dashed red horizontal line indicates the 200 nm upper size reference.
Table 3. Comparison of intraluminal vesicle (ILV) diameter measurements obtained from literature-based meta-analyses and in situ experiments. This table summarizes ILV diameter measurements derived from TEM-based literature meta-analysis, cryo-EM-based literature meta-analysis, and TEM-based in situ validation using cell lines. For each dataset, the average number of ILV measured for each study (N), the number of studies or experimental conditions analyzed (n), mean ILV diameter, standard deviation (SD), and lower and upper limits of the 95% confidence interval (CI) are reported.

2.3. Comparison of ILV and sEV Size Using Orthogonal Methods

To examine whether the size conservation of ILVs is reflected in the size of sEVs, HEK293T cells were used to isolate sEVs by differential ultracentrifugation and filtration. The isolated sEVs were characterized by TEM, NTA, and dSTORM. Representative TEM micrographs are shown in Figure 3A, in which sEVs exhibit a characteristic bilayer, cup-shaped morphology. Diameters of sEVs measured from TEM micrographs were estimated across five biological replicates, with the majority of sEVs observed to be smaller than 200 nm (Figure 3B). The mean ± SD size distribution of sEVs measured by NTA is shown in Figure 3C. The distribution exhibited a unimodal profile, with the highest particle concentration observed within the sub-200 nm range. Most detected particles were distributed between approximately 50 and 200 nm in diameter, with a gradual decrease in particle concentration above 200 nm. Comparison of sEV size measurements obtained by TEM and NTA revealed that sEVs derived from the same cell source and biological replicates were significantly larger when measured by NTA than by TEM (Figure 3D). Phenotypic characterization of sEVs was performed using dSTORM. Representative images are shown in Figure 3E, in which individual sEVs were detected as single clusters. Phosphatidylserine affinity labeling (PAN-EV) was used to delineate the sEV membrane, and the presence of the canonical tetraspanins CD9, CD63, and CD81 was also detected by a combined tetraspanin antibody mix. Co-localization of PAN-EV signals with the tetraspanin trio was observed at the level of individual sEVs. Diameters obtained from automated EV acquisition using CODI were compared with diameters measured by TEM, NTA, and dSTORM. In addition, the size of the sEVs measured by TEM, NTA, and dSTORM showed no significant difference and no difference when compared with the mean ILV diameter from each study measured (Figure 3F).
Figure 3. Characterization of sEV size and comparison with ILV dimensions. (A) Representative TEM micrographs of sEVs isolated from HEK293T cells. The left panel shows a low-magnification field (scale bar: 500 nm), and the right panel shows a magnified view highlighting the characteristic cup-shaped, bilayer morphology of sEVs (scale bar: 200 nm). (B) sEV diameters measured from TEM micrographs across five biological replicates. Individual data points represent single vesicle measurements. Mean ± SD values for each biological replicate were as follows: replicate 1, 80.81 ± 31.51 nm (N = 37); replicate 2, 94.54 ± 23.97 nm (N = 29); replicate 3, 112.1 ± 39.91 nm (N = 28); replicate 4, 83.13 ± 22.01 nm (N = 23); replicate 5, 109.4 ± 31.15 nm (N = 26). Analysis of sEV diameters measured by TEM across biological replicates showed that biological replicate 3 exhibited significantly larger sEV diameters compared with biological replicates 1 and 4, whereas biological replicate 5 was significantly larger than biological replicates 1 and 4. Statistical significance was determined using ordinary one-way ANOVA followed by Tukey’s multiple comparisons test (Red dashed line showing 200 nm). (C) NTA-derived size distribution of sEVs across five biological replicates, plotted as mean ± SD particle concentration as a function of diameter. The distribution exhibited a unimodal profile with the highest particle concentration within the sub-200 nm range (Red dashed line showing 200 nm). (D) Comparison of mean sEV diameters measured by TEM and NTA for the same five biological replicates. Mean ± SD sEV diameter measured by TEM was 96.00 ± 14.47 nm, whereas mean ± SD diameter measured by NTA was 123.7 ± 9.507 nm. An unpaired two-tailed t-test revealed a statistically significant difference between TEM and NTA measurements. (E) Representative dSTORM images of individual sEVs showing phenotypic characterization. Single sEVs were detected as discrete clusters, with phosphatidylserine labeling (PAN-EV) delineating the vesicle membrane and co-localization of a mix of canonical tetraspanins CD9, CD63, and CD81 observed at the level of individual sEVs. Scale bar 100 nm. (F) Comparison of vesicle diameters measured using orthogonal methods, including TEM-derived sEVs, NTA-derived sEVs, dSTORM-derived sEVs, and TEM-derived ILVs (Red dashed line showing 200 nm). Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s multiple comparisons test. sEV diameters measured by NTA and dSTORM were significantly larger than ILV diameters measured by TEM, whereas no significant difference was observed between TEM-derived sEV and ILV measurements. (* p < 0.005, ** p < 0.01, *** p < 0.001).

3. Discussion

In this study, membrane-bound, roughly spherical vesicles located within the lumen of an MVB were operationally classified as ILV. While this was performed to systematically assess the size of ILVs, it is possible that a small fraction of these ILVs may be hard to distinguish from resembling structures found in other endolysosomal or autophagic compartments, such as lysosomes or amphisomes, and indeed, there is some evidence that these other compartments can give rise to EVs [14,69].
Despite characterization of ILVs and sEVs in individual reports, a unified quantitative framework defining ILV size across species, imaging modalities, and experimental contexts has not been established. Notably, the MISEV2018 guidelines do not specify a quantitative size range for ILV-derived exosomes or sEVs, whereas MISEV2023 indicates their size as generally smaller than 200 nm [70,71]. Importantly, this size claim lacks primary data or citations. Therefore, the present study provides empirical support for this proposed boundary. Although biophysical constraints governing ILV formation have been proposed [72] and ILV sizes have been reported in specific systems [20], these observations have not been systematically integrated across taxa or methodologies. In the present study, this gap was addressed through the integration of literature-based meta-analyses and direct comparison of ILV dimensions with sEV sizes measured using independent approaches. Thus, our study represents the first detailed evaluation of ILV size conservation across species and imaging platforms, and their comparison to sEVs.
Because the initial meta-analysis relied primarily on TEM-based measurements, known technical limitations associated with this modality were considered. TEM analysis can be influenced by fixation, dehydration, and staining artifacts, potentially biasing size estimation [73]. To further address this concern, a second meta-analysis focusing on cryo-EM studies was conducted. Cryo-EM has been widely recommended for EV imaging due to improved preservation of near-native morphology and reduced fixation-related artifacts [13,74,75]. Cryo-EM measurements likewise showed that ILV diameters were predominantly below 200 nm, with only one ILV of 205.5 nm observed. These findings suggest that the observed size distribution is unlikely to arise solely from methodological artifacts.
A notable limitation in previous ultrastructural studies concerns the discrimination between MVBs and amphisomes—hybrid organelles formed through fusion of MVBs with autophagosomes. Although both compartments contain intraluminal vesicles with comparable morphological appearance in electron micrographs, reliable distinction requires integration of molecular markers of the autophagic pathways [14,69]. Moreover, detailed ultrastructural characterization of amphisomes remains relatively limited, further constraining confident assignment of these compartments in conventional EM datasets.
The conserved upper size limit of approximately 200 nm of ILVs across species and imaging platforms is consistent with biophysical constraints governing ESCRT-mediated ILV biogenesis. Inward budding of the endosomal membrane requires high curvature and protein crowding, conditions that favor vesicle diameters in the range of approximately 30–150 nm [72]. ESCRT III-mediated neck constriction further enforces size uniformity, while geometric packing constraints within MVBs, typically measuring approximately 300–1000 nm in diameter, favor the formation of multiple smaller ILVs. Consistent with these principles, median ILV diameters of approximately 40–120 nm have been reported across taxa [76].
An additional source of heterogeneity may originate at the level of ILV biogenesis. Electron microscopy reveals that ILVs within a single MVB can differ markedly in diameter and electron density, suggesting the coexistence of multiple vesicle subpopulations prior to secretion. This intravesicular heterogeneity may contribute to the broad size distributions reported for sEVs in conditioned media by NTA and qNano and supports the notion that sEVs represent a structurally and functionally diverse population rather than a uniform entity. Notably, uniform ILV size distributions within an intracellular vesicle may raise consideration of potential virus particles [13]. The observed intravesicular ILV heterogeneity contributes to the broad size distributions reported for sEVs in conditioned media by NTA and qNano and supports the notion that sEVs may represent a structurally and functionally diverse population rather than a uniform entity.
To further examine the relationship between ILVs and their secreted counterparts, HEK293T cells were selected for downstream sEV analysis due to their high transfection efficiency, robust EV yield, and scalability [77,78]. Because sEVs released following MVB or amphisome limiting membrane plasma membrane fusion are considered secreted ILVs, comparison of ILV and sEV size distributions provides experimental support for their endosomal origin. sEVs isolated from HEK293T cells by differential ultracentrifugation were characterized using TEM, NTA, and dSTORM microscopy. Across all three orthogonal approaches, sEV diameters consistently remained below 200 nm, with closely concordant size distributions.
Taken together, the cumulative evidence supports that EVs larger than approximately 200 nm are unable to arise from ILVs and instead are derived from ectosomal shedding at the plasma membrane. This addresses a knowledge gap in EV heterogeneity, aiding standardization in MISEV guidelines and future biogenesis models. Thus, the present study provides a quantitative framework for ILV size conservation that aids in distinguishing endosome-derived sEVs from other EV subtypes in future studies.

4. Materials and Methods

4.1. Meta-Analysis of Intraluminal Vesicle Dimensions from Transmission Electron Microscopy

A meta-analysis was conducted to evaluate the size distribution of intraluminal vesicles (ILVs) identified in transmission electron microscopy (TEM) micrographs. A systematic literature search was performed in the PubMed database on 19 January 2026, using the following search strategy: (exosome AND TEM) OR (small + EV AND TEM) OR (MVB AND TEM) OR (ILV AND TEM). The initial search yielded 895 records. Studies were included in the analysis if they met the following criteria: (1) original research articles presenting multivesicular body (MVB) TEM micrographs with clearly visible intraluminal vesicles; (2) explicit measurements or quantifiable data of ILV dimensions; and (3) presence of scale bars or dimensional calibration references in micrographs. Studies lacking any of these criteria were excluded (n = 855). Following the application of inclusion and exclusion criteria, 40 original research articles were selected for meta-analysis (Figure 1A).

4.2. Meta-Analysis of Intraluminal Vesicle Dimensions from Cryo-Electron Microscopy

A second comprehensive meta-analysis was undertaken to assess ILV size distributions identified in cryo-EM datasets. A systematic literature search was conducted in the PubMed database on 20 December 2025, using the following search query: (cryo-EM OR cryo-ET) AND (“multivesicular body” OR “multivesicular bodies” OR intraluminal). The initial search retrieved 11 records. Studies were included if they satisfied the following criteria: (1) original research articles containing MVB cryo-EM or cryo-ET micrographs with resolved intraluminal vesicles; (2) quantifiable measurements of ILV dimensions; and (3) calibration references enabling dimensional analysis. Articles, which did not meet these criteria, were excluded (n = 3). Following screening, 8 original research articles met the inclusion criteria and were included in the meta-analysis (Figure 2A).

4.3. Image Analysis

All ILV and sEV diameter measurements derived from TEM, cryo-EM, and in situ experiments were quantified using ImageJ (version 1.54g). ILVs were selected based on the presence of roughly spherical, membrane-bounded structures observed within multivesicular bodies. For each micrograph, the image scale was first calibrated using the scale bar provided in the original figure. Individual vesicles were then manually outlined using the freehand selection tool, and each selected particle was added to the ROI Manager to ensure traceability and avoid duplicate measurements (Supplementary Information Figure S1). Vesicle size was quantified using the Feret diameter measurement for each ROI, and all measurements were exported for downstream analysis (Figure 1B).

4.4. Cell Culture

Human embryonic kidney (HEK293T) cells (Catalogue No. 12022001, ECACC, Salisbury, UK) were used in this study. Cells were cultured in Dulbecco’s Modified Eagle’s Medium (Catalogue No. D6046; Merck Group, Darmstadt, Germany) supplemented with 10% fetal bovine serum (Catalogue No. 10270106; Thermo Fisher Scientific, Waltham, MA, USA) and antibiotic–antimycotic solution (Catalogue No. A5955; Merck Group, Darmstadt, Germany). Cultures were maintained at 37 °C in a humidified atmosphere containing 5% CO2 (≥90% humidity). Cells were passaged three times per week. Polymerase chain reaction (PCR) was routinely performed to assess mycoplasma contamination using the following primers: GTTTGATCCTGGCTCAGGAYDAAC and GAAAGGAGGTRWTCCAYCCSCAC [79].

4.5. Isolation of Small Extracellular Vesicles from Cell Culture Supernatants

HEK293T cells were seeded at a density of 5 × 106 cells per mL and incubated for 24 h in serum-free media (20 mL per 150 mm culture plate). sEVs were isolated using a differential centrifugation protocol with modifications to a previously described method [80]. The conditioned medium was subjected to sequential centrifugation and filtration steps to enrich for sEVs. Cells were first removed by centrifugation at 500× g for 10 min at room temperature. The resulting supernatant was passed through a 5 µm pore size filter (Merck Group, Darmstadt, Germany) and centrifuged at 2000× g for 20 min at 4 °C to remove very large extracellular vesicles. The supernatant was then filtered through a 0.8 µm pore size filter (Merck Group, Darmstadt, Germany) and centrifuged at 14,000× g for 40 min at 4 °C to remove large extracellular vesicles. The resulting supernatant was filtered through a 0.2 µm pore size filter (Merck Group, Darmstadt, Germany) and subjected to ultracentrifugation at 100,000× g for 2.5 h at 4 °C using an Optima XPN-100 ultracentrifuge (Beckman Coulter, Inc., Brea, CA, USA) to pellet sEVs. The resulting pellet was washed by resuspension in sterile phosphate-buffered saline (PBS) and subjected to an identical ultracentrifugation step. The final sEV pellet was resuspended in 1× PBS for subsequent analyses.

4.6. Transmission Electron Microscopy Imaging of Small Extracellular Vesicles

For TEM imaging of sEVs, we applied a previously described method [81]. Briefly, samples were fixed in 2% paraformaldehyde (paraformaldehyde, powder, 95%, 158127, Sigma Aldrich, St. Louis, MO, USA) in 1× PBS for 30 min at 4 °C. Then, they were incubated for 15 min on low, discharged at 7.2 V for 60 s, and carbon-coated on 100 mesh copper grids using a BalTec MED 020 Coating System (Baltec, Pfäffikon, Switzerland). After washing with 1× PBS and fixing with glutaraldehyde 1% (Sigma-Aldrich, St. Louis, MO, USA) for 5 min at 4 °C. Grids were washed again and dried with filter paper. The grids were treated with 2% aqueous uranyl acetate (Sigma-Aldrich, St. Louis, MO, USA) for 2 min to generate negative staining. Samples were washed and dried, then analyzed with FEI Tecnai G2 Spirit TEM (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a Morada digital camera (Olympus Soft Image Solutions GmbH, Muenster, Germany). All TEM procedures were undertaken at the University of Valencia’s Electron Microscopy facility.

4.7. Nanoparticle Tracking Analysis

Size distribution and particle concentration of sEVs were determined using nanoparticle tracking analysis (NTA) on a ZetaView PMX120 instrument (Particle Metrix, Meerbusch, Germany). Samples were diluted in phosphate-buffered saline (PBS, 1×) to achieve optimal particle concentrations (50–200 particles per frame). Analysis was performed across 11 distinct positions on each sample, with two sequential measurement cycles acquired per position for data averaging and quality assurance. Instrument settings were optimized as follows: camera shutter speed, 100; camera sensitivity, 80; and frame rate, 30 frames per second. Data were processed and analyzed using the instrument’s integrated software, which automatically tracks individual particle trajectories to derive size distributions and concentration estimates.

4.8. Super Resolution Microscopy

Phenotyping of sEVs was performed using direct stochastic optical reconstruction microscopy (dSTORM) combined with the EV Profiler 2 assay platform (Oxford Nanoimaging, Oxford, UK). Super-resolution images of sEVs were acquired using a Nanoimager S microscope (Oxford Nanoimaging, Oxford, UK) equipped with a 100×, 1.4 numerical aperture oil immersion objective, an XYZ closed-loop piezo stage, and a single-molecule localization microscopy (SMLM) system featuring four laser lines and two spatially separated emission channels (split at 640 nm). Sample preparation followed the manufacturer’s protocol. The EV Profiler 2 assay chip surface was initially coated with surface reagent, followed by application of the Tetraspanin Trio capture reagent conjugated to biotinylated capture molecules. sEV samples (concentration range 10 × 109–10 × 1011 particles per mL) were applied to the functionalized chip surface and incubated for 75 min at 30–45 rpm on a laboratory rocker for immobilization. Following immobilization and fixation, the surfaces were stained sequentially with Pan-EV Detection (488 nm) and Tetraspanin Trio Detection (561 nm) probes. Post-fixation was performed following staining, and the chip surface was incubated with dSTORM imaging buffer prior to image acquisition. Image acquisition was conducted in dSTORM mode using total internal reflection fluorescence (TIRF) microscopy for sequential dual-channel imaging. The 488 nm and 561 nm laser lines were operated at 84% and 45% power, respectively. Fluorescence localization data were processed and analyzed using the CODI platform (https://alto.codi.bio/, accessed on 7 December 2025) with AutoEV Profiler essentials acquisition settings. Localization clusters comprising ≥10 individual localizations were designated as sEVs. sEVs were classified as marker positive when ≥10 individual localizations were detected in a cluster in the corresponding detection channel.

4.9. Statistical Analysis

Descriptive statistics, including mean, standard deviation (SD), standard error of the mean (SEM), and lower and upper limits of the 95% confidence interval (CI), were calculated for all datasets. Frequency distributions were generated where appropriate, and Gaussian fitting was applied to visualize central tendencies without inferential interpretation. Statistical comparisons between multiple groups were performed using ordinary one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test. Pairwise comparisons between two groups were performed using unpaired two-tailed t-tests with Welch’s correction when variances were unequal. For non-parametric comparisons involving multiple groups, the Kruskal–Wallis test followed by Dunn’s multiple comparisons test was applied. Statistical significance was defined as p < 0.05, and significance levels are indicated in figures using asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). All statistical analyses were performed using GraphPad Prism (version 10.3.1).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms27073176/s1.

Author Contributions

Conceptualization: S.G., E.I.B. and X.O.; Methodology: S.G., R.L. and B.Y.; Investigation: S.G., B.M.K., B.R.B., M.A.F., L.M., A.T., H.H. and L.K.; Formal analysis: S.G.; Writing—Original Draft: S.G., E.I.B. and X.O.; Writing—Review and Editing: S.G., E.I.B. and X.O.; Funding acquisition: E.I.B. and X.O. All authors have read and agreed to the published version of the manuscript.

Funding

EU’s Horizon 2020 Research and Innovation Programme under Grant agreement No. 739593, OTKA FK 147023, EXCELLENCE 151417, Advanced Grant 150767, 2019-2.1.7-ERA-NET-2021-00015, and NVKP_16-1-2016-0004 grants of the Hungarian National Research, Development and Innovation Office (NKFIH), the Higher Education Excellence Program (FIKP) and the Therapeutic Thematic Programme TKP2021-EGA-23, RRF-2.3.121-2022-00003 (National Cardiovascular Laboratory Program), VEKOP-2.3.2-162016-00002, VEKOP-2.3.3-15-2017-00016, EKÖP-2024-237 and Stipendium Hungaricum Scholarship 2021.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author.

Acknowledgments

We extend sincere gratitude to Mario Soriano (Centro Investigácion Príncipe Felipe, Valencia, Spain) for his assistance with TEM.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ghosal, S.; Bodnár, B.R.; Kestecher, B.M.; Nagy, Á.; László, T.; Yilmaz, B.; Zeng, Y.; Szabó, A.; Bödör, C.; I Buzás, E.; et al. Revolutionizing therapeutics: Unleashing the power of extracellular vesicles for disease intervention. Curr. Opin. Physiol. 2025, 43, 100815. [Google Scholar] [CrossRef] [Scilit]
  2. Ripoll, L.; Zickler, A.M.; Vader, P.; El Andaloussi, S.; Verweij, F.J.; van Niel, G. Biology and therapeutic potential of extracellular vesicle targeting and uptake. Nat. Rev. Mol. Cell Biol. 2026. [Google Scholar] [CrossRef] [Scilit]
  3. Kamerkar, S.; LeBleu, V.S.; Sugimoto, H.; Yang, S.; Ruivo, C.F.; Melo, S.A.; Lee, J.J.; Kalluri, R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017, 546, 498–503. [Google Scholar] [CrossRef] [Scilit]
  4. Kestecher, B.M.; Németh, K.; Ghosal, S.; Sayour, N.V.; Gergely, T.G.; Bodnár, B.R.; Försönits, A.I.; Sódar, B.W.; Oesterreicher, J.; Holnthoner, W.; et al. Reduced circulating CD63(+) extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans. Cardiovasc. Diabetol. 2024, 23, 368. [Google Scholar] [CrossRef] [Scilit]
  5. Van Delen, M.; Derdelinckx, J.; Wouters, K.; Nelissen, I.; Cools, N. A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy. J. Extracell. Vesicles 2024, 13, e12458. [Google Scholar] [CrossRef] [Scilit]
  6. Figueroa-Valdés, A.I.; Luz-Crawford, P.; Herrera-Luna, Y.; Georges-Calderón, N.; García, C.; Tobar, H.E.; Araya, M.J.; Matas, J.; Donoso-Meneses, D.; de la Fuente, C.; et al. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: Preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis. J. Nanobiotechnol. 2025, 23, 13. [Google Scholar] [CrossRef] [Scilit]
  7. Brembati, V.; Crescenti, D.; Geviti, A.; Rossini, E.; Cazzaniga, F.A.; Moda, F.; Zanier, E.R.; Guerrera, G.; Battistini, L.; Baiardi, S.; et al. Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer’s dementia. Alzheimers Res. Ther. 2026, 18, 3. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Xu, R.; Rai, A.; Chen, M.; Suwakulsiri, W.; Greening, D.W.; Simpson, R.J. Extracellular vesicles in cancer—Implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 2018, 15, 617–638. [Google Scholar] [CrossRef] [Scilit]
  9. Osteikoetxea, X.; Németh, A.; Sódar, B.W.; Vukman, K.V.; Buzás, E.I. Extracellular vesicles in cardiovascular disease: Are they Jedi or Sith? J. Physiol. 2016, 594, 2881–2894. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Thompson, A.G.; Gray, E.; Heman-Ackah, S.M.; Mäger, I.; Talbot, K.; Andaloussi, S.E.; Wood, M.J.; Turner, M.R. Extracellular vesicles in neurodegenerative disease—Pathogenesis to biomarkers. Nat. Rev. Neurol. 2016, 12, 346–357. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Buzas, E.I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 2023, 23, 236–250. [Google Scholar] [CrossRef] [Scilit]
  12. Zhao, Y.G.; Codogno, P.; Zhang, H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat. Rev. Mol. Cell Biol. 2021, 22, 733–750. [Google Scholar] [CrossRef] [Scilit]
  13. Zhao, Y.G.; Zhang, H. Autophagosome maturation: An epic journey from the ER to lysosomes. J. Cell Biol. 2019, 218, 757–770. [Google Scholar] [CrossRef] [Scilit]
  14. Ganesan, D.; Cai, Q. Understanding amphisomes. Biochem. J. 2021, 478, 1959–1976. [Google Scholar] [CrossRef] [Scilit]
  15. Hurley, J.H. ESCRTs are everywhere. EMBO J. 2015, 34, 2398–2407. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Vietri, M.; Radulovic, M.; Stenmark, H. The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol. 2020, 21, 25–42. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Babst, M. MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr. Opin. Cell Biol. 2011, 23, 452–457. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. Di Naro, M.; Petronio Petronio, G.; Mukhtar, F.; Cutuli, M.A.; Magnifico, I.; Falcone, M.; Brancazio, N.; Guarnieri, A.; Di Marco, R.; Nicolosi, D. Extracellular Vesicles in Bacteria, Archaea, and Eukaryotes: Mechanisms of Inter-Kingdom Communication and Clinical Implications. Microorganisms 2025, 13, 636. [Google Scholar] [CrossRef] [Scilit]
  19. Liu, H.; Dong, T.; Dong, C.; Yang, F.; Zhou, Q.; Guan, C.; Wang, W. Plant-derived exosome-like nanovesicles: A novel therapeutic perspective for skin diseases. J. Nanobiotechnol. 2025, 23, 640. [Google Scholar] [CrossRef] [Scilit]
  20. Maurya, D.K.; Berghard, A.; Bohm, S. A multivesicular body-like organelle mediates stimulus-regulated trafficking of olfactory ciliary transduction proteins. Nat. Commun. 2022, 13, 6889. [Google Scholar] [CrossRef] [Scilit]
  21. Reibman, J.; Hsu, Y.; Chen, L.C.; Kumar, A.; Su, W.C.; Choy, W.; Talbot, A.; Gordon, T. Size fractions of ambient particulate matter induce granulocyte macrophage colony-stimulating factor in human bronchial epithelial cells by mitogen-activated protein kinase pathways. Am. J. Respir. Cell Mol. Biol. 2002, 27, 455–462. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Bache, K.G.; Brech, A.; Mehlum, A.; Stenmark, H. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol. 2003, 162, 435–442. [Google Scholar] [CrossRef] [Scilit]
  23. Luhtala, N.; Odorizzi, G. Bro1 coordinates deubiquitination in the multivesicular body pathway by recruiting Doa4 to endosomes. J. Cell Biol. 2004, 166, 717–729. [Google Scholar] [CrossRef] [Scilit]
  24. Tse, Y.C.; Mo, B.; Hillmer, S.; Zhao, M.; Lo, S.W.; Robinson, D.G.; Jiang, L. Identification of multivesicular bodies as prevacuolar compartments in Nicotiana tabacum BY-2 cells. Plant Cell 2004, 16, 672–693. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Wang, J.; Li, Y.; Lo, S.W.; Hillmer, S.; Sun, S.S.; Robinson, D.G.; Jiang, L. Protein mobilization in germinating mung bean seeds involves vacuolar sorting receptors and multivesicular bodies. Plant Physiol. 2007, 143, 1628–1639. [Google Scholar] [CrossRef] [Scilit]
  26. Darehshouri, A.; Affenzeller, M.; Lütz-Meindl, U. Cell death upon H2O2 induction in the unicellular green alga Micrasterias. Plant Biol. 2008, 10, 732–745. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Altick, A.L.; Baryshnikova, L.M.; Vu, T.Q.; von Bartheld, C.S. Quantitative analysis of multivesicular bodies (MVBs) in the hypoglossal nerve: Evidence that neurotrophic factors do not use MVBs for retrograde axonal transport. J. Comp. Neurol. 2009, 514, 641–657. [Google Scholar] [CrossRef] [Scilit]
  28. Sahoo, S.; Klychko, E.; Thorne, T.; Misener, S.; Schultz, K.M.; Millay, M.; Ito, A.; Liu, T.; Kamide, C.; Agrawal, H.; et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ. Res. 2011, 109, 724–728. [Google Scholar] [CrossRef] [Scilit]
  29. Eden, E.R.; Burgoyne, T.; Edgar, J.R.; Sorkin, A.; Futter, C.E. The relationship between ER-multivesicular body membrane contacts and the ESCRT machinery. Biochem. Soc. Trans. 2012, 40, 464–468. [Google Scholar] [CrossRef] [Scilit]
  30. Zeigerer, A.; Gilleron, J.; Bogorad, R.L.; Marsico, G.; Nonaka, H.; Seifert, S.; Epstein-Barash, H.; Kuchimanchi, S.; Peng, C.G.; Ruda, V.M.; et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 2012, 485, 465–470. [Google Scholar] [CrossRef] [Scilit]
  31. Chivet, M.; Hemming, F.; Pernet-Gallay, K.; Fraboulet, S.; Sadoul, R. Emerging role of neuronal exosomes in the central nervous system. Front. Physiol. 2012, 3, 145. [Google Scholar] [CrossRef] [Scilit]
  32. Wang, J.; Tse, Y.C.; Hinz, G.; Robinson, D.G.; Jiang, L. Storage globulins pass through the Golgi apparatus and multivesicular bodies in the absence of dense vesicle formation during early stages of cotyledon development in mung bean. J. Exp. Bot. 2012, 63, 1367–1380. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Wanner, G.; Schäfer, T.; Lütz-Meindl, U. 3-D analysis of dictyosomes and multivesicular bodies in the green alga Micrasterias denticulata by FIB/SEM tomography. J. Struct. Biol. 2013, 184, 203–211. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Edgar, J.R.; Eden, E.R.; Futter, C.E. Hrs- and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic 2014, 15, 197–211. [Google Scholar] [CrossRef] [Scilit]
  35. Safavian, D.; Goring, D.R. Secretory activity is rapidly induced in stigmatic papillae by compatible pollen, but inhibited for self-incompatible pollen in the Brassicaceae. PLoS ONE 2013, 8, e84286. [Google Scholar] [CrossRef] [Scilit]
  36. Hofmann, D.; Tenzer, S.; Bannwarth, M.B.; Messerschmidt, C.; Glaser, S.F.; Schild, H.; Landfester, K.; Mailänder, V. Mass spectrometry and imaging analysis of nanoparticle-containing vesicles provide a mechanistic insight into cellular trafficking. ACS Nano 2014, 8, 10077–10088. [Google Scholar] [CrossRef] [Scilit]
  37. Nagashima, S.; Jirintai, S.; Takahashi, M.; Kobayashi, T.; Tanggis; Nishizawa, T.; Kouki, T.; Yashiro, T.; Okamoto, H. Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J. Gen. Virol. 2014, 95, 2166–2175. [Google Scholar] [CrossRef] [Scilit]
  38. Santo, N.; Fascio, U.; Torres, F.; Guazzoni, N.; Tremolada, P.; Bettinetti, R.; Mantecca, P.; Bacchetta, R. Toxic effects and ultrastructural damages to Daphnia magna of two differently sized ZnO nanoparticles: Does size matter? Water Res. 2014, 53, 339–350. [Google Scholar] [CrossRef] [Scilit]
  39. Soonsawad, P.; Paavolainen, L.; Upla, P.; Weerachatyanukul, W.; Rintanen, N.; Espinoza, J.; McNerney, G.; Marjomäki, V.; Cheng, R.H. Permeability changes of integrin-containing multivesicular structures triggered by picornavirus entry. PLoS ONE 2014, 9, e108948. [Google Scholar] [CrossRef] [Scilit]
  40. Hyenne, V.; Apaydin, A.; Rodriguez, D.; Spiegelhalter, C.; Hoff-Yoessle, S.; Diem, M.; Tak, S.; Lefebvre, O.; Schwab, Y.; Goetz, J.G.; et al. RAL-1 controls multivesicular body biogenesis and exosome secretion. J. Cell Biol. 2015, 211, 27–37. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  41. Mazzeo, C.; Cañas, J.A.; Zafra, M.P.; Rojas Marco, A.; Fernández-Nieto, M.; Sanz, V.; Mittelbrunn, M.; Izquierdo, M.; Baixaulli, F.; Sastre, J.; et al. Exosome secretion by eosinophils: A possible role in asthma pathogenesis. J. Allergy Clin. Immunol. 2015, 135, 1603–1613. [Google Scholar] [CrossRef] [Scilit]
  42. Petrizzo, A.; Conte, C.; Tagliamonte, M.; Napolitano, M.; Bifulco, K.; Carriero, V.; De Stradis, A.; Tornesello, M.L.; Buonaguro, F.M.; Quaglia, F.; et al. Functional characterization of biodegradable nanoparticles as antigen delivery system. J. Exp. Clin. Cancer Res. 2015, 34, 114. [Google Scholar] [CrossRef] [Scilit]
  43. Chen, Q.; Wang, N.; Zhu, M.; Lu, J.; Zhong, H.; Xue, X.; Guo, S.; Li, M.; Wei, X.; Tao, Y.; et al. TiO2 nanoparticles cause mitochondrial dysfunction, activate inflammatory responses, and attenuate phagocytosis in macrophages: A proteomic and metabolomic insight. Redox Biol. 2018, 15, 266–276. [Google Scholar] [CrossRef] [Scilit]
  44. Chihanga, T.; Ma, Q.; Nicholson, J.D.; Ruby, H.N.; Edelmann, R.E.; Devarajan, P.; Kennedy, M.A. NMR spectroscopy and electron microscopy identification of metabolic and ultrastructural changes to the kidney following ischemia-reperfusion injury. Am. J. Physiol. Ren. Physiol. 2018, 314, F154–F166. [Google Scholar] [CrossRef] [Scilit]
  45. Bai, X.; Guo, Y.; Shi, Y.; Lin, J.; Tarique, I.; Wang, X.; Vistro, W.A.; Huang, Y.; Chen, H.; Haseeb, A.; et al. In vivo multivesicular bodies and their exosomes in the absorptive cells of the zebrafish (Danio Rerio) gut. Fish Shellfish Immunol. 2019, 88, 578–586. [Google Scholar] [CrossRef] [Scilit]
  46. Adamakis, I.S.; Eleftheriou, E.P. Structural Evidence of Programmed Cell Death Induction by Tungsten in Root Tip Cells of Pisum sativum. Plants 2019, 8, 62. [Google Scholar] [CrossRef] [Scilit]
  47. Lammel, T.; Mackevica, A.; Johansson, B.R.; Sturve, J. Endocytosis, intracellular fate, accumulation, and agglomeration of titanium dioxide (TiO2) nanoparticles in the rainbow trout liver cell line RTL-W1. Environ. Sci. Pollut. Res. Int. 2019, 26, 15354–15372. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  48. Rupp, U.; Ziegler, A. The effect of exuviae ingestion on lysosomal calcium accumulation and the presence of exosomes in the hepatopancreas of Porcellio scaber. J. Struct. Biol. 2019, 208, 107392. [Google Scholar] [CrossRef] [Scilit]
  49. Vistro, W.A.; Zhang, Y.; Bai, X.; Yang, P.; Huang, Y.; Qu, W.; Baloch, A.S.; Wu, R.; Tarique, I.; Chen, Q. In Vivo Autophagy Up-Regulation of Small Intestine Enterocytes in Chinese Soft-Shelled Turtles during Hibernation. Biomolecules 2019, 9, 682. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  50. Zhao, D.Y.; Qi, Q.Q.; Long, X.; Li, X.; Chen, F.X.; Yu, Y.B.; Zuo, X.L. Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome. Physiol. Int. 2019, 106, 225–235. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  51. Belli, M.; Rinaudo, P.; Palmerini, M.G.; Ruggeri, E.; Antonouli, S.; Nottola, S.A.; Macchiarelli, G. Pre-Implantation Mouse Embryos Cultured In Vitro under Different Oxygen Concentrations Show Altered Ultrastructures. Int. J. Environ. Res. Public Health 2020, 17, 3384. [Google Scholar] [CrossRef] [Scilit]
  52. Campos, C.; Lázaro-Rodríguez, T.G.; Fragoso-Soriano, R.; Fernández, F.J. Vesicular transport and secretion of penicillin G in Penicillium rubens P2-32-T. Arch. Microbiol. 2020, 202, 1257–1262. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  53. Polat, I.; Amutkan Mutlu, D.; Suludere, Z. Accessory glands of male reproductive system in Pseudochorthippus parallelus parallelus (Zetterstedt, 1821) (Orthoptera: Acrididae): A light and electron microscopic study. Microsc. Res. Tech. 2020, 83, 232–238. [Google Scholar] [CrossRef] [Scilit]
  54. Qu, W.; Tarique, I.; Deng, B.; Zhang, Y.; Haseeb, A.; Chen, Q.; Yang, P. Cellular evidence of autophagy in Sertoli cells during spermatogenesis in goats. Theriogenology 2020, 154, 237–245. [Google Scholar] [CrossRef] [Scilit]
  55. Zhang, X.W.; Zhou, J.C.; Peng, D.; Hua, F.; Li, K.; Yu, J.J.; Lv, X.X.; Cui, B.; Liu, S.S.; Yu, J.M.; et al. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy 2020, 16, 782–796. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  56. Bora, M.S.; Sarma, K.P. Anatomical and ultrastructural alterations in Ceratopteris pteridoides under cadmium stress: A mechanism of cadmium tolerance. Ecotoxicol. Environ. Saf. 2021, 218, 112285. [Google Scholar] [CrossRef] [Scilit]
  57. Steiner, P.; Buchner, O.; Andosch, A.; Holzinger, A.; Lütz-Meindl, U.; Neuner, G. Winter survival of the unicellular green alga Micrasterias denticulata: Insights from field monitoring and simulation experiments. Protoplasma 2021, 258, 1335–1346. [Google Scholar] [CrossRef] [Scilit]
  58. Chatzimeletiou, K.; Petrogiannis, N.; Sioga, A.; Emmanouil-Nikoloussi, E.N.; Panagiotidis, Y.; Prapa, M.; Patrikiou, A.; Filippa, M.; Zervakakou, G.; Papanikolaou, K.; et al. The human embryo following biopsy on day 5 versus day 3: Viability, ultrastructure and spindle/chromosome configurations. Reprod. Biomed. Online 2022, 45, 219–233. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  59. Zhu, Z.; Feng, Y.; Pan, Y.; Fan, S.; Meng, X.; Wang, Y.; Liu, J.; Dai, C.; Feng, J.; Peng, L.; et al. Cellular evidence and spatial distribution of endosomal biosynthesis and autophagy in intestinal immune barrier cells of crucian carp (Carassius carassius). Fish Shellfish Immunol. 2024, 150, 109605. [Google Scholar] [CrossRef] [Scilit]
  60. Bergner, T.; Cortez Rayas, L.; Freimann, G.; Read, C.; von Einem, J. Secondary Envelopment of Human Cytomegalovirus Is a Fast Process Utilizing the Endocytic Compartment as a Major Membrane Source. Biomolecules 2024, 14, 1149. [Google Scholar] [CrossRef] [Scilit]
  61. Ma, D.; Deng, B.; Sun, C.; McComb, D.W.; Gu, C. The Mechanical Microenvironment Regulates Axon Diameters Visualized by Cryo-Electron Tomography. Cells 2022, 11, 2533. [Google Scholar] [CrossRef] [Scilit]
  62. Tavakoli, A.; Hu, S.; Ebrahim, S.; Kachar, B. Hemifusomes and interacting proteolipid nanodroplets mediate multi-vesicular body formation. Nat. Commun. 2025, 16, 4609. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  63. Flores, M.D.; Sawaya, M.R.; Boyer, D.R.; Zink, S.; Tovmasyan, S.; Saucedo, A.; Richards, L.S.; Zee, C.T.; Cardenas, J.; Fioriti, L.; et al. Structural insights into functional regulation of the human CPEB3 prion by an amyloid-forming segment. Structure 2025, 33, 1314–1324.e5. [Google Scholar] [CrossRef] [Scilit]
  64. Tao, C.L.; Tian, C.L.; Liu, Y.T.; Lu, Z.H.; Qi, L.; Li, X.W.; Li, C.; Shen, X.; Gu, M.L.; Huang, W.L.; et al. “Kiss-shrink-run” unifies mechanisms for synaptic vesicle exocytosis and hyperfast recycling. Science 2025, 390, eads7954. [Google Scholar] [CrossRef] [Scilit]
  65. Sykora, U.M.; O’Sullivan, T.J.; Halfon, Y.; Fontana, J.; Harris, M. The architecture of membrane structures involved in hepatitis C virus genome replication revealed under close-to-native conditions by cryo-electron tomography. J. Gen. Virol. 2025, 106, 002168. [Google Scholar] [CrossRef] [Scilit]
  66. Groen, J.; Gazi, A.; Kapishnikov, S.; Brelot, A.; Vos, M.; Enninga, J.; Pereiro, E.; Sartori-Rupp, A. Cryo-CLXEM introduces cryo-SXT to bridge the resolution gap in cryo-CLEM. Commun. Biol. 2025, 8, 1677. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  67. Alcantara, C.L.; Pöge, M.; Baumeister, W.; Plitzko, J.M.; de Souza, W. The subcellular architecture of Paratrypanosoma confusum revealed by CryoET: A window into early trypanosome evolution. Proc. Natl. Acad. Sci. USA 2025, 122, e2521233122. [Google Scholar] [CrossRef] [Scilit]
  68. Ning, J.; Glausier, J.R.; Warshamanage, R.; Gunther-Cummins, L.; Burnley, T.; Palmer, C.M.; Gonzalez-Burgos, G.; Miyamae, T.; Wang, J.; Carlisle, D.; et al. Uncovering synaptic and cellular nanoarchitecture of brain tissue via seamless in situ trimming and milling for cryo-electron tomography. bioRxiv 2025. [Google Scholar] [CrossRef] [Scilit]
  69. Visnovitz, T.; Lenzinger, D.; Koncz, A.; Vizi, P.M.; Bárkai, T.; Vukman, K.V.; Galinsoga, A.; Németh, K.; Fletcher, K.; Komlósi, Z.I.; et al. A ‘torn bag mechanism’ of small extracellular vesicle release via limiting membrane rupture of en bloc released amphisomes (amphiectosomes). eLife 2025, 13, RP95828. [Google Scholar] [CrossRef]
  70. Théry, C.; Witwer, K.W.; Aikawa, E.; Alcaraz, M.J.; Anderson, J.D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G.K.; et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018, 7, 1535750. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  71. Welsh, J.A.; Goberdhan, D.C.I.; O’Driscoll, L.; Buzas, E.I.; Blenkiron, C.; Bussolati, B.; Cai, H.; Di Vizio, D.; Driedonks, T.A.P.; Erdbrügger, U.; et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 2024, 13, e12404, Correction in J. Extracell. Vesicles 2024, 13, e12451. https://doi.org/10.1002/jev2.12451.. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  72. Liese, S.; Wenzel, E.M.; Kjos, I.; Rojas Molina, R.; Schultz, S.W.; Brech, A.; Stenmark, H.; Raiborg, C.; Carlson, A. Protein crowding mediates membrane remodeling in upstream ESCRT-induced formation of intraluminal vesicles. Proc. Natl. Acad. Sci. USA 2020, 117, 28614–28624. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  73. Rikkert, L.G.; Nieuwland, R.; Terstappen, L.; Coumans, F.A.W. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J. Extracell. Vesicles 2019, 8, 1555419. [Google Scholar] [CrossRef] [Scilit]
  74. Chuo, S.T.; Chien, J.C.; Lai, C.P. Imaging extracellular vesicles: Current and emerging methods. J. Biomed. Sci. 2018, 25, 91. [Google Scholar] [CrossRef] [Scilit]
  75. Yuana, Y.; Koning, R.I.; Kuil, M.E.; Rensen, P.C.; Koster, A.J.; Bertina, R.M.; Osanto, S. Cryo-electron microscopy of extracellular vesicles in fresh plasma. J. Extracell. Vesicles 2013, 2, 21494. [Google Scholar] [CrossRef] [Scilit]
  76. Arya, S.B.; Collie, S.P.; Parent, C.A. The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 2024, 34, 90–108. [Google Scholar] [CrossRef] [Scilit]
  77. Chen, Y.W.; Lin, Y.H.; Ho, C.C.; Chen, C.Y.; Yu, M.H.; Lee, A.K.; Chiu, S.C.; Cho, D.Y.; Shie, M.Y. High-yield extracellular vesicle production from HEK293T cells encapsulated in 3D auxetic scaffolds with cyclic mechanical stimulation for effective drug carrier systems. Biofabrication 2024, 16, 045035. [Google Scholar] [CrossRef] [Scilit]
  78. Zhang, W.; Obuchi, S.; Teramura, Y. Analysis of cellular responses following interaction with extracellular vesicles derived from HEK293T and human adipose derived stem cells. Sci. Rep. 2025, 15, 11835. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  79. Jean, A.; Tardy, F.; Allatif, O.; Grosjean, I.; Blanquier, B.; Gerlier, D. Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes. PLoS ONE 2017, 12, e0172358. [Google Scholar] [CrossRef] [Scilit]
  80. Osteikoetxea, X.; Balogh, A.; Szabó-Taylor, K.; Németh, A.; Szabó, T.G.; Pálóczi, K.; Sódar, B.; Kittel, Á.; György, B.; Pállinger, É.; et al. Improved characterization of EV preparations based on protein to lipid ratio and lipid properties. PLoS ONE 2015, 10, e0121184. [Google Scholar] [CrossRef] [Scilit]
  81. Osteikoetxea, X.; Silva, A.; Lázaro-Ibáñez, E.; Salmond, N.; Shatnyeva, O.; Stein, J.; Schick, J.; Wren, S.; Lindgren, J.; Firth, M.; et al. Engineered Cas9 extracellular vesicles as a novel gene editing tool. J. Extracell. Vesicles 2022, 11, e12225. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.